[DOI] [PMC free article] [PubMed] [Google Scholar] Knopman DS, Amieva H, Petersen RC, Chtelat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT
1140), XE991 (2000), and linopirdine (1999) were obtained from Tocris Bioscience (Bristol, UK)
However, despite the good pharmacological properties shown by this molecule on several cancers, its use in the clinic is problematic because of its strong diuretic properties
Glucagon-like peptide 1 (GLP-1) receptor agonists use during pregnancy: safety data from regulatory clinical trials
Q: Is there a deadline to file
This includes only using capsules and powders (no tablets that require tableting aids) to achieve the purest possible formulations